Having trouble accessing articles? Reset your cache.

FT1050: Preliminary Phase Ib data

Preliminary data from an open-label, U.S. Phase Ib trial in 15 evaluable patients with hematologic malignancies who have undergone non-myeloablative conditioning therapy showed that dual umbilical cord blood

Read the full 281 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE